跳至主要内容
临床试验/TCTR20231108001
TCTR20231108001尚未招募1 期

Effect of spot urine sodium guided diuretics regimen in patients with acute decompensated heart failure

/A0 个研究点目标入组 50 人开始时间: 2023年11月8日最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 N/A (No limit)(—)
性别
All

入选标准

  • 1.Age more than 18-year-old with hospital admission with the principal diagnosis of acute decompensated heart failure within 24 hours of the hospital visit.
  • 2.Presence of at least one symptoms and signs of volume overload: orthopnea, paroxysmal nocturnal dyspnea, jugular venous distension, lung crepitation.

排除标准

  • 1.Hydrochlorothiazide, acetazolamide, or tolvaptan use within 48 hours prior to the enrollment period
  • 2.Systolic blood pressure < 90 mmHg or mean arterial pressure < 65 mmHg
  • 3.Inotrope or vasopressor usage
  • 4.Glomerular function rate < 30 ml/min/1.73m2
  • 5.Use of renal replacement therapy or ultrafiltration
  • 6.Exposure to intravenous contrast agents anticipated within the next 72 hours
  • 7.Need for invasive mechanical ventilation
  • 8.Concurrent diagnosis of an acute coronary syndrome
  • 9.History of cardiac transplantation and/or ventricular assist device
  • 10.Pregnant or currently breastfeeding

研究者

发起方
/A

相似试验

Effect of spot urine sodium guided diuretics regimen... | 临床试验